Weave Communications Inc(WEAV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:01 PM ET (Korea 9/12 05:01)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.26 | Insider Own | 13.97% | Shs Outstand | 79.9M | Perf Week | -0.27% |
| Market Cap | 0.58B | Forward P/E | 29.54 | EPS next Y | 45.59% | Insider Trans | - | Shs Float | 68.8M | Perf Month | 45.91% |
| Enterprise Value | 0.56B | PEG | 0.47 | EPS next Q | 0.04 | Inst Own | 87.88% | Short Float | 7.69% | Perf Quarter | 33.88% |
| Income | -0.02B | P/S | 2.27 | EPS this Y | 112.5% | Inst Trans | 7.33% | Short Ratio | 1.99 | Perf Half Y | 53.89% |
| Sales | 0.26B | P/B | 6.88 | EPS next 5Y | 62.77% | ROA | -9.95% | Short Interest | 5.29M | Perf YTD | -3.69% |
| Book/sh | 1.06 | P/C | 7.45 | EPS past 3/5Y | 21.39% 11.11% | ROE | -25.08% | 52W High | -8.63% ($8.00) | Perf Year | -8.51% |
| Cash/sh | 0.98 | P/FCF | 53.07 | Sales past 3/5Y | 18.92% 24.5% | ROIC | -16.51% | 52W Low | 72.41% ($4.24) | Perf 3Y | -17.68% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 35.67% | Gross Margin | 72.18% | Volatility(W/M) | 0.41% 1.32% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.16 | Sales Y/Y TTM | 16.73% | Oper. Margin | -7.99% | ATR (14) | 0.16 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.07 | EPS Q/Q | 53.44% | Profit Margin | -7.97% | RSI (14) | 62.49 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.07 | Sales Q/Q | 15.52% | SMA20 | 2.64% ($7.12) | Beta | 1.68 | Target Price | $7.4 |
| Payout | - | Debt/Eq | 0.6 | Earnings | 2026/8/6 | SMA50 | 7.98% ($6.77) | Rel Volume | 0.44 | Prev Close | $7.3 |
| Employees | 904 | LT Debt/Eq | 0.46 | EPS/Sales Surpr. | 14.29% -0.49% | SMA200 | 20.49% ($6.07) | Avg Volume(3M) | 2.66M | Price | $7.31 |
| IPO | 2021/11/11 | Option/Short | Yes/Yes | Trades | 4570 | Volume | 1,174,505 | Change | 0.14% |
Company
WEAV is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
📞 A U.S. healthcare IT company that provides an AI-powered, all-in-one communication, patient engagement, and payment SaaS platform designed for small medical practices such as dental offices, optometry clinics, and veterinary hospitals. It unifies phone, texting, scheduling, payment, and reviews into a single workflow, digitizing the day-to-day operations of medical practices.
Over the past 1 year, on the higher side
9% below its 1-year high.
WEAV has weak earning power
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +112.5% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Long-term returns are close to the market
Would have changed by -17.7% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 87.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
WCLD 0.01%
XITK 0.01%
XSW 0.01%
DAT 0.01%
BUYO 0.00%It ranks #4 in the industry
Based on market cap of $585M.
WEAV $585M PER -
VEEV $42B PER 43.2
BTSG $12B PER 43.9
TEM $11B PER -
FAQ
What kind of company is WEAV?
WEAV belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of WEAV?
The market cap of WEAV is approximately $585M, ranking 3,100 within its sector.
What is the 52-week high and low for WEAV?
WEAV has recorded a 52-week high of $8.00 and a low of $4.24.
